MPLT
MPLT
NASDAQ · Biotechnology

Maplight Therapeutics Inc

$31.43
+0.78 (+2.54%)
As of Jun 25, 2:10 PM ET ·
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +101.0% upside
Low Target $44.21
Average Target $63.19
High Target $83.67
Current Price $31.43
Current
$31.43
Target
$63.19
$44.21 $63.19 avg $83.67
Scenario Analysis
Bear Case
$44.21
40.7%
Low target
Base Case
$63.19
+101.0%
Avg target
Bull Case
$83.67
+166.2%
High target
Risk/Reward
4.1x
Highly favorable
Price in Context
52-Week High
$33.28
-5.6% from high
52-Week Low
$12.24
+156.8% from low
Target vs 52W High
$63.19
+89.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +5.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -46.4%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +191.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -9.5%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -36.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.5%